- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 323/40 - Y being a hydrogen or a carbon atom
Patent holdings for IPC class C07C 323/40
Total number of patents in this class: 28
10-year publication summary
|
0
|
0
|
2
|
1
|
0
|
2
|
0
|
3
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7932 |
4 |
| Adeka Corporation | 1366 |
4 |
| Nihon Nohyaku Co., Ltd. | 330 |
4 |
| Lighthouse Pharmaceuticals, Inc. | 11 |
4 |
| Samsung Display Co., Ltd. | 35888 |
2 |
| Dongjin Semichem Co., Ltd. | 486 |
2 |
| AstraZeneca AB | 2857 |
1 |
| Abbvie Inc. | 1812 |
1 |
| Acousia Therapeutics GmbH | 11 |
1 |
| Apogee Biotechnology Corporation | 14 |
1 |
| Symrise GmbH & Co. KG | 53 |
1 |
| United Therapeutics Corporation | 313 |
1 |
| Calico Life Sciences LLC | 102 |
1 |
| Kos Therapeutics, Inc. | 9 |
1 |
| Other owners | 0 |